Report

Identification of c-MYC as a Target of the APC Pathway

Science  04 Sep 1998:
Vol. 281, Issue 5382, pp. 1509-1512
DOI: 10.1126/science.281.5382.1509

You are currently viewing the abstract.

View Full Text
As a service to the community, AAAS/Science has made this article free with registration.

Abstract

The adenomatous polyposis coli gene (APC) is a tumor suppressor gene that is inactivated in most colorectal cancers. Mutations of APC cause aberrant accumulation of β-catenin, which then binds T cell factor–4 (Tcf-4), causing increased transcriptional activation of unknown genes. Here, the c-MYC oncogene is identified as a target gene in this signaling pathway. Expression of c-MYC was shown to be repressed by wild-type APC and activated by β-catenin, and these effects were mediated through Tcf-4 binding sites in the c-MYC promoter. These results provide a molecular framework for understanding the previously enigmatic overexpression of c-MYC in colorectal cancers.

  • * To whom correspondence should be addressed. E-mail: kinzlke{at}welchlink.welch.jhu.edu

View Full Text

Cited By...